Jun Hanaoka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jun Hanaoka has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
Yasuhiko Ohshio
Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan
9 shared publicationsRyosuke Kaku
Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan
8 shared publicationsTakuya Shiratori
Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan
8 shared publicationsKeigo Okamoto
Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan
7 shared publications- Keigo Okamoto
Department of Cardiothoracic Surgery, Shiga University of Medical Science, Shiga, Japan
7 shared publications Yo Kawaguchi
Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan
7 shared publications
Latest Publications
- 9 December 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (3) , 2036-2045
Surgical approach and tumor size influence outcomes in thymoma: a retrospective analysis of 70 cases
Background Minimally invasive surgery (MIS) has become increasingly applied in thymoma, but its feasibility for large tumors remains contested. Methods We retrospectively reviewed 70 patients, treated between 2001 and 2023, with Masaoka stage I–II thymomas. Patients were stratified according to surgical approach—open surgery (OP, n = 20) or MIS (video- or robot-assisted, n = 50)—and tumor size using both preoperative CT and specimen measurements with 5- and 6 cm thresholds. Perioperative outcomes were compared using propensity score matching (PSM). Results MIS was associated with less intraoperative blood loss, shorter drainage duration, and shorter hospital stay compared with OP, without conversions to OP. These benefits persisted after PSM. The use of MIS gradually expanded to include tumors ≥ 5 cm, with perioperative outcomes improving in a later phase. Within the MIS cohort, tumor size ≥ 5 cm did not significantly affect operative time, blood loss, or recovery. Exploratory analyses using a 6 cm cutoff showed comparable overall outcomes. Oncologic events were rare, with only one recurrence observed in the entire cohort. Conclusions MIS offers superior short-term perioperative outcomes compared with OP and appears feasible for selected patients with large thymomas. However, its long-term oncologic validity—particularly regarding pleural dissemination and late recurrence—requires confirmation in multicenter prospective studies. Graphical Abstract
- 9 December 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (3) , 2036-2045
Surgical approach and tumor size influence outcomes in thymoma: a retrospective analysis of 70 cases
Background Minimally invasive surgery (MIS) has become increasingly applied in thymoma, but its feasibility for large tumors remains contested. Methods We retrospectively reviewed 70 patients, treated between 2001 and 2023, with Masaoka stage I–II thymomas. Patients were stratified according to surgical approach—open surgery (OP, n = 20) or MIS (video- or robot-assisted, n = 50)—and tumor size using both preoperative CT and specimen measurements with 5- and 6 cm thresholds. Perioperative outcomes were compared using propensity score matching (PSM). Results MIS was associated with less intraoperative blood loss, shorter drainage duration, and shorter hospital stay compared with OP, without conversions to OP. These benefits persisted after PSM. The use of MIS gradually expanded to include tumors ≥ 5 cm, with perioperative outcomes improving in a later phase. Within the MIS cohort, tumor size ≥ 5 cm did not significantly affect operative time, blood loss, or recovery. Exploratory analyses using a 6 cm cutoff showed comparable overall outcomes. Oncologic events were rare, with only one recurrence observed in the entire cohort. Conclusions MIS offers superior short-term perioperative outcomes compared with OP and appears feasible for selected patients with large thymomas. However, its long-term oncologic validity—particularly regarding pleural dissemination and late recurrence—requires confirmation in multicenter prospective studies. Graphical Abstract
- Open Access
- 1 March 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (3) , 2232-2245
Dynamic chest radiography in post-lobectomy recovery: a novel approach to evaluating pulmonary function and thoracic structures in patients with primary lung cancer
Background: Lobectomy for lung cancer leads to changes in thoracic structures and reduced pulmonary function, but real-time evaluation of compensatory mechanisms has been challenging. This study employed dynamic chest radiography to examine post-lobectomy changes in the projected lung area and excursion of diaphragm, as evaluated by sequential chest radiography, and determine their correlation with pulmonary function recovery. Methods: This single-center and cross-sectional study was conducted at the Shiga University of Medical Science Hospital and included 65 patients who underwent lobectomy between May 2018 and December 2020. Dynamic chest radiography was performed preoperatively and at 1, 3, 6, and 12 months postoperatively alongside standard pulmonary function tests. We evaluated the postoperative trends in pulmonary function, projected lung area, and excursion of diaphragm. The results were analyzed using the Mann-Whitney U test and Fisher’s exact test. Additionally, correlations between changes in the pulmonary function and dynamic chest radiography (DCR) parameters were assessed using Spearman’s rank correlation coefficients. The utility of DCR in predicting postoperative pulmonary function recovery was further examined using receiver operating characteristic (ROC) curve analysis. Results: Significant correlations were observed between the maximum projected lung area and pulmonary function recovery, particularly in upper lobectomy cases (correlation with vital capacity at 1 month postoperatively: r=0.72, PConclusions: Dynamic chest radiography, which assessed the projected lung area and excursion of diaphragm, emerged as a promising non-invasive tool for monitoring post-lobectomy recovery and guiding rehabilitation efforts. These findings indicate its potential as an early predictor of pulmonary recovery, advocating for its integration into the perioperative care of patients with lung cancer. Future research should expand patient cohorts and refine predictive models using preoperative dynamic chest radiography to enhance post-lobectomy outcomes.
- 1 March 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (3) , 2232-2245
Open AccessDynamic chest radiography in post-lobectomy recovery: a novel approach to evaluating pulmonary function and thoracic structures in patients with primary lung cancer
Background: Lobectomy for lung cancer leads to changes in thoracic structures and reduced pulmonary function, but real-time evaluation of compensatory mechanisms has been challenging. This study employed dynamic chest radiography to examine post-lobectomy changes in the projected lung area and excursion of diaphragm, as evaluated by sequential chest radiography, and determine their correlation with pulmonary function recovery. Methods: This single-center and cross-sectional study was conducted at the Shiga University of Medical Science Hospital and included 65 patients who underwent lobectomy between May 2018 and December 2020. Dynamic chest radiography was performed preoperatively and at 1, 3, 6, and 12 months postoperatively alongside standard pulmonary function tests. We evaluated the postoperative trends in pulmonary function, projected lung area, and excursion of diaphragm. The results were analyzed using the Mann-Whitney U test and Fisher’s exact test. Additionally, correlations between changes in the pulmonary function and dynamic chest radiography (DCR) parameters were assessed using Spearman’s rank correlation coefficients. The utility of DCR in predicting postoperative pulmonary function recovery was further examined using receiver operating characteristic (ROC) curve analysis. Results: Significant correlations were observed between the maximum projected lung area and pulmonary function recovery, particularly in upper lobectomy cases (correlation with vital capacity at 1 month postoperatively: r=0.72, PConclusions: Dynamic chest radiography, which assessed the projected lung area and excursion of diaphragm, emerged as a promising non-invasive tool for monitoring post-lobectomy recovery and guiding rehabilitation efforts. These findings indicate its potential as an early predictor of pulmonary recovery, advocating for its integration into the perioperative care of patients with lung cancer. Future research should expand patient cohorts and refine predictive models using preoperative dynamic chest radiography to enhance post-lobectomy outcomes.
- Open Access
- 1 January 2025
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 11 (1) , cr.25-0504
Pulmonary Artery Intimal Sarcoma Mimicking Intraluminal Seeding: A Case Report
INTRODUCTION: Pulmonary artery intimal sarcoma (PAIS) is a rare vascular malignancy. Complete surgical resection is crucial for favorable outcomes; however, intraoperative delineation of the tumor extent poses a significant challenge.CASE PRESENTATION: A 63-year-old woman with suspected PAIS underwent a left pneumonectomy under cardiopulmonary bypass. Despite macroscopically clear margins, histopathological examination of the pulmonary artery (PA) stump exhibited tumor infiltration, necessitating reevaluation. We identified multiple skip-like intraluminal nodules along the PA and performed resection and subsequent reconstruction utilizing an autologous pericardial patch. The final pathology demonstrated not only nodular lesions but also creeping intimal infiltration in segments without gross abnormalities.CONCLUSIONS: Although PAIS typically exhibits contiguous spread along the intima, the presence of skip-like nodules and subtle creeping infiltration is rare, complicating intraoperative assessment. Comprehensive intraoperative and pathological assessments are essential to achieve a complete resection.
- 1 January 2025
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 11 (1) , cr.25-0504
Open AccessPulmonary Artery Intimal Sarcoma Mimicking Intraluminal Seeding: A Case Report
INTRODUCTION: Pulmonary artery intimal sarcoma (PAIS) is a rare vascular malignancy. Complete surgical resection is crucial for favorable outcomes; however, intraoperative delineation of the tumor extent poses a significant challenge.CASE PRESENTATION: A 63-year-old woman with suspected PAIS underwent a left pneumonectomy under cardiopulmonary bypass. Despite macroscopically clear margins, histopathological examination of the pulmonary artery (PA) stump exhibited tumor infiltration, necessitating reevaluation. We identified multiple skip-like intraluminal nodules along the PA and performed resection and subsequent reconstruction utilizing an autologous pericardial patch. The final pathology demonstrated not only nodular lesions but also creeping intimal infiltration in segments without gross abnormalities.CONCLUSIONS: Although PAIS typically exhibits contiguous spread along the intima, the presence of skip-like nodules and subtle creeping infiltration is rare, complicating intraoperative assessment. Comprehensive intraoperative and pathological assessments are essential to achieve a complete resection.
- Open Access
- 1 August 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (8) , 5277-5287
Visual analysis of pulmonary blood flow in pulmonary circulation assessment: differences between two variant algorithms for processing dynamic images
Background: In the quantitative assessment of pulmonary blood flow, two different processing algorithms [cross-correlation calculation processing (CCC-pro) and reference frame subtraction processing (RFS-pro)] within dynamic imaging systems have been reported to exhibit high correlations with conventional measurement methods. However, reports still need to evaluate these two processing algorithms regarding the different aspects of pulmonary blood flow. This study aimed to analyze the differences in pulmonary circulation. Methods: We conducted a cross-sectional study to evaluate patients with lung cancer who underwent radical surgery, simultaneous dynamic chest radiography (DCR), and pulmonary perfusion scintigraphy (PPS). We assessed the correlation between PPS and two algorithms (CCC-pro and RFS-pro) regarding calculated blood flow ratio (BFR) using Pearson’s correlation and linear regression analysis. Additionally, we evaluated consistency using the Bland-Altman analysis. We compared the pulmonary blood flow distributions across six-division lung fields and evaluated each method’s blood flow images and histograms of pixel values. Results: From May 2018 to December 2020, we consecutively enrolled 46 patients with lung cancer who met the inclusion criteria (40 male patients, with a mean age of 72.91 years). In these patients, CCC-pro and RFS-pro were correlated (R=0.718, Pvs. R=0.549, PConclusions: The CCC-pro algorithm was useful for quantifying BFRs, whereas the RFS-pro algorithm accurately evaluated blood flow distribution in lung fields. Further algorithm development is required to enable versatile pulmonary blood flow analysis.
- 1 August 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (8) , 5277-5287
Open AccessVisual analysis of pulmonary blood flow in pulmonary circulation assessment: differences between two variant algorithms for processing dynamic images
Background: In the quantitative assessment of pulmonary blood flow, two different processing algorithms [cross-correlation calculation processing (CCC-pro) and reference frame subtraction processing (RFS-pro)] within dynamic imaging systems have been reported to exhibit high correlations with conventional measurement methods. However, reports still need to evaluate these two processing algorithms regarding the different aspects of pulmonary blood flow. This study aimed to analyze the differences in pulmonary circulation. Methods: We conducted a cross-sectional study to evaluate patients with lung cancer who underwent radical surgery, simultaneous dynamic chest radiography (DCR), and pulmonary perfusion scintigraphy (PPS). We assessed the correlation between PPS and two algorithms (CCC-pro and RFS-pro) regarding calculated blood flow ratio (BFR) using Pearson’s correlation and linear regression analysis. Additionally, we evaluated consistency using the Bland-Altman analysis. We compared the pulmonary blood flow distributions across six-division lung fields and evaluated each method’s blood flow images and histograms of pixel values. Results: From May 2018 to December 2020, we consecutively enrolled 46 patients with lung cancer who met the inclusion criteria (40 male patients, with a mean age of 72.91 years). In these patients, CCC-pro and RFS-pro were correlated (R=0.718, Pvs. R=0.549, PConclusions: The CCC-pro algorithm was useful for quantifying BFRs, whereas the RFS-pro algorithm accurately evaluated blood flow distribution in lung fields. Further algorithm development is required to enable versatile pulmonary blood flow analysis.
- Open Access
- 1 December 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (12) , 7159-7161
Future expectations for respiratory disease assessment in dynamic chest radiography
Future expectations for respiratory disease assessment in dynamic chest radiography
- 1 December 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (12) , 7159-7161
Open AccessFuture expectations for respiratory disease assessment in dynamic chest radiography
Future expectations for respiratory disease assessment in dynamic chest radiography
- Open Access
- 1 October 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (10) , 5593-5604
Relationship between pulmonary blood flow and volume following lung resection using dynamic perfusion digital radiography
Background: Surgical intervention for lung resection can cause ventilation-perfusion mismatches and affect gas exchange; however, minimally invasive assessment of blood flow is difficult. This study aimed to evaluate changes in pulmonary blood flow after radical lung cancer surgery using a minimally invasive dynamic digital chest radiography system. Methods: We evaluated 64 patients who underwent radical lobectomies. Postoperative changes in pulmonary blood flow, assessed using dynamic chest radiography-based blood flow ratios (BFRs), were compared with the temporal evolution of both functional lung volumes (FLVs) and estimated lung weight (ELW) derived from computed tomography (CT) volumetry. Results: FLVs on the affected side gradually recovered over time from the lowest value observed 3 months after surgery in all procedures. BFRs on the affected side also showed a gradual recovery from the lowest value 1 month after surgery, except for left upper lobectomies (LULs). In LULs, FLVs and ELWs increased proportionally up to 3 months after surgery, with lung volumes continuing to increase thereafter. The recovery of BFRs differed depending on the resected lobe. Conclusions: A relationship between pulmonary blood flow and FLV was observed in the postoperative period. Despite varying compensatory responses depending on the surgical procedure, FLV recovery coincided with increased pulmonary blood flow.
- 1 October 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (10) , 5593-5604
Open AccessRelationship between pulmonary blood flow and volume following lung resection using dynamic perfusion digital radiography
Background: Surgical intervention for lung resection can cause ventilation-perfusion mismatches and affect gas exchange; however, minimally invasive assessment of blood flow is difficult. This study aimed to evaluate changes in pulmonary blood flow after radical lung cancer surgery using a minimally invasive dynamic digital chest radiography system. Methods: We evaluated 64 patients who underwent radical lobectomies. Postoperative changes in pulmonary blood flow, assessed using dynamic chest radiography-based blood flow ratios (BFRs), were compared with the temporal evolution of both functional lung volumes (FLVs) and estimated lung weight (ELW) derived from computed tomography (CT) volumetry. Results: FLVs on the affected side gradually recovered over time from the lowest value observed 3 months after surgery in all procedures. BFRs on the affected side also showed a gradual recovery from the lowest value 1 month after surgery, except for left upper lobectomies (LULs). In LULs, FLVs and ELWs increased proportionally up to 3 months after surgery, with lung volumes continuing to increase thereafter. The recovery of BFRs differed depending on the resected lobe. Conclusions: A relationship between pulmonary blood flow and FLV was observed in the postoperative period. Despite varying compensatory responses depending on the surgical procedure, FLV recovery coincided with increased pulmonary blood flow.
- Open Access
- 30 August 2023
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 72 (11) , 3755-3764
Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancer
Programmed cell death-ligand 1 (PD-L1) on tumor cells can be degraded to soluble form (sPD-L1) and enter circulation, however, the clinical significances of sPD-L1 in peripheral blood remains to be elucidated in non-small-cell lung cancer (NSCLC). We monitored plasma sPD-L1 levels during perioperative periods and evaluated PD-L1-positive cells in tumor tissues in patients with operable NSCLC. Then the correlation between preoperative plasma sPD-L1 levels and relapse-free survival (RFS) was analyzed retrospectively. In patients who underwent radical surgery (n = 61), plasma sPD-L1 levels (median; 63.5 pg/mL) significantly increased 1 month after surgery (72.2 pg/mL, P < 0.001). The combined score of PD-L1-positive cells including tumor cells and tumor-associated macrophages (TAMs) was significantly associated with preoperative plasma sPD-L1 levels. In patients with high levels of preoperative plasma sPD-L1, the probability of 5-year RFS was significantly poor for patients with low PD-L1 expression intensity of tumor cells (tcPD-L1) compared with those with high tcPD-L1 (33.3% vs. 87.5%, respectively, P = 0.016; 95% CI, 0.013–0.964). In former group, PD-L1-positive TAMs were markedly infiltrating compared with those from latter group (246.4 vs. 76.6 counts/mm2, respectively, P = 0.003). In NSCLC, plasma sPD-L1 can reflect the accumulation of PD-L1-posotive TAMs, not just PD-L1-positive tumor cells. In patients with high levels of preoperative plasma sPD-L1, the prognoses after surgery depends on which PD-L1-positive cells, tumor cells or TAMs, are the primary source of the sPD-L1. Thus, measuring both plasma sPD-L1 levels and PD-L1 expression status of tumor cells and TAMs is of benefit for assessment of postoperative prognosis in operable NSCLC.
- 30 August 2023
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 72 (11) , 3755-3764
Open AccessPrognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancer
Programmed cell death-ligand 1 (PD-L1) on tumor cells can be degraded to soluble form (sPD-L1) and enter circulation, however, the clinical significances of sPD-L1 in peripheral blood remains to be elucidated in non-small-cell lung cancer (NSCLC). We monitored plasma sPD-L1 levels during perioperative periods and evaluated PD-L1-positive cells in tumor tissues in patients with operable NSCLC. Then the correlation between preoperative plasma sPD-L1 levels and relapse-free survival (RFS) was analyzed retrospectively. In patients who underwent radical surgery (n = 61), plasma sPD-L1 levels (median; 63.5 pg/mL) significantly increased 1 month after surgery (72.2 pg/mL, P < 0.001). The combined score of PD-L1-positive cells including tumor cells and tumor-associated macrophages (TAMs) was significantly associated with preoperative plasma sPD-L1 levels. In patients with high levels of preoperative plasma sPD-L1, the probability of 5-year RFS was significantly poor for patients with low PD-L1 expression intensity of tumor cells (tcPD-L1) compared with those with high tcPD-L1 (33.3% vs. 87.5%, respectively, P = 0.016; 95% CI, 0.013–0.964). In former group, PD-L1-positive TAMs were markedly infiltrating compared with those from latter group (246.4 vs. 76.6 counts/mm2, respectively, P = 0.003). In NSCLC, plasma sPD-L1 can reflect the accumulation of PD-L1-posotive TAMs, not just PD-L1-positive tumor cells. In patients with high levels of preoperative plasma sPD-L1, the prognoses after surgery depends on which PD-L1-positive cells, tumor cells or TAMs, are the primary source of the sPD-L1. Thus, measuring both plasma sPD-L1 levels and PD-L1 expression status of tumor cells and TAMs is of benefit for assessment of postoperative prognosis in operable NSCLC.
- Open Access
- 28 December 2022
- Published by Wiley in Cancer Science
- Vol. 114 (3) , 750-763
Depletion of tumor‐associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin
In lung cancer, tumor‐associated macrophages (TAMs), especially M2‐like TAMs, represent the main tumor progression components in the tumor microenvironment (TME). Therefore, M2‐like TAMs may serve as a therapeutic target. The purpose of this study was to investigate the effect of M2‐like TAM depletion in the TME on tumor growth and chemotherapy response in lung cancer. The levels of secreted monocyte chemoattractant protein (MCP‐1) and prostaglandin E2 (PGE2) in the supernatants of lung cancer cell lines A549 and LLC were evaluated via ELISA. Cell migration assays were performed to assess the recruitment ability of macrophage cell lines THP‐1 and J774‐1 cells. Differentiation of macrophages was assessed via flow cytometry. Immunohistochemical staining was performed to visualize M2‐like TAMs in transplanted lung cancer in mouse. We used the COX‐2 inhibitor nimesulide to inhibit the secretion of MCP‐1 and PGE2, which promotes macrophage migration and M2‐like differentiation. Nimesulide treatment decreased the secretion of MCP‐1 and PGE2 from lung cancer cells. Nimesulide treatment suppressed the migration of macrophages by blocking MCP‐1. Lung cancer supernatant induced the differentiation of macrophages toward the M2‐like phenotype, and nimesulide treatment inhibited M2‐like differentiation by blocking MCP‐1 and PGE2. In the lung cancer mouse model, treatment with nimesulide depleted M2‐like TAMs in the TME and enhanced the tumor inhibitory effect of cisplatin. Our results indicated that blocking the secretion of MCP‐1 and PGE2 from tumor cells depleted M2‐like TAMs in the TME and the combination therapy with cisplatin considerably suppressed tumor growth in the LLC mouse model.
- 28 December 2022
- Published by Wiley in Cancer Science
- Vol. 114 (3) , 750-763
Open AccessDepletion of tumor‐associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin
In lung cancer, tumor‐associated macrophages (TAMs), especially M2‐like TAMs, represent the main tumor progression components in the tumor microenvironment (TME). Therefore, M2‐like TAMs may serve as a therapeutic target. The purpose of this study was to investigate the effect of M2‐like TAM depletion in the TME on tumor growth and chemotherapy response in lung cancer. The levels of secreted monocyte chemoattractant protein (MCP‐1) and prostaglandin E2 (PGE2) in the supernatants of lung cancer cell lines A549 and LLC were evaluated via ELISA. Cell migration assays were performed to assess the recruitment ability of macrophage cell lines THP‐1 and J774‐1 cells. Differentiation of macrophages was assessed via flow cytometry. Immunohistochemical staining was performed to visualize M2‐like TAMs in transplanted lung cancer in mouse. We used the COX‐2 inhibitor nimesulide to inhibit the secretion of MCP‐1 and PGE2, which promotes macrophage migration and M2‐like differentiation. Nimesulide treatment decreased the secretion of MCP‐1 and PGE2 from lung cancer cells. Nimesulide treatment suppressed the migration of macrophages by blocking MCP‐1. Lung cancer supernatant induced the differentiation of macrophages toward the M2‐like phenotype, and nimesulide treatment inhibited M2‐like differentiation by blocking MCP‐1 and PGE2. In the lung cancer mouse model, treatment with nimesulide depleted M2‐like TAMs in the TME and enhanced the tumor inhibitory effect of cisplatin. Our results indicated that blocking the secretion of MCP‐1 and PGE2 from tumor cells depleted M2‐like TAMs in the TME and the combination therapy with cisplatin considerably suppressed tumor growth in the LLC mouse model.
- Open Access
- 1 September 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (9) , 3321-3334
Mediastinal lymph node evaluation, especially at station 4L, in left upper lobe lung cancer
Original Article Mediastinal lymph node evaluation, especially at station 4L, in left upper lobe lung cancer Jun Hanaoka, Makoto Yoden, Keigo Okamoto, Ryosuke Kaku, Yasuhiko Ohshio
- 1 September 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (9) , 3321-3334
Open AccessMediastinal lymph node evaluation, especially at station 4L, in left upper lobe lung cancer
Original Article Mediastinal lymph node evaluation, especially at station 4L, in left upper lobe lung cancer Jun Hanaoka, Makoto Yoden, Keigo Okamoto, Ryosuke Kaku, Yasuhiko Ohshio
- Open Access
- 14 July 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (9) , 3234-3244
Reliability of dynamic perfusion digital radiography as an alternative to pulmonary perfusion scintigraphy in predicting postoperative lung function and complications
Original Article Reliability of dynamic perfusion digital radiography as an alternative to pulmonary perfusion scintigraphy in predicting postoperative lung function and complications Jun Hanaoka, Takuya Shiratori, Keigo Okamoto, Ryosuke Kaku, Yo Kawaguchi, Yasuhiko Ohshio, Akinaga Sonoda
- 14 July 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (9) , 3234-3244
Open AccessReliability of dynamic perfusion digital radiography as an alternative to pulmonary perfusion scintigraphy in predicting postoperative lung function and complications
Original Article Reliability of dynamic perfusion digital radiography as an alternative to pulmonary perfusion scintigraphy in predicting postoperative lung function and complications Jun Hanaoka, Takuya Shiratori, Keigo Okamoto, Ryosuke Kaku, Yo Kawaguchi, Yasuhiko Ohshio, Akinaga Sonoda